Parallel Advisors »

Phoenix Biotech Acquisition shares owned by Parallel Advisors

Quarter-by-quarter ownership of Phoenix Biotech Acquisition (CEROW) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Phoenix Biotech Acquisition

Tip: Access up to 7 years of quarterly data

All positions including Phoenix Biotech Acquisition held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phoenix Biotech Acquisition by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $365 28k 0.01
2025-06-30 $1.2k 50k 0.02
2025-03-31 $725 50k 0.01

More positions owned by Parallel Advisors

Ishares S&p 500 Index Etf (IVV)
Ishares Core S&p Total U.s. Stock Market Etf Etf (ITOT)
Corcept Therapeutics Stock (CORT)
Apple Stock (AAPL)
Nvidia Corp Stock (NVDA)
Microsoft Stock (MSFT)
Ishares U.s. Equity Factor Rotation Active Etf Etf (DYNF)
Amazon.com Stock (AMZN)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Google Stock (GOOGL)
Cvb Finl Corp Stock (CVBF)
Vanguard Large Cap Etf (VV)
Janus Henderson Mortgage-backed Securities Etf Etf (JMBS)
Ishares Core Msci Eafe Etf Etf (IEFA)
Avantis International Equity Etf Etf (AVDE)

View all positions for Parallel Advisors

Top funds holding Phoenix Biotech Acquisition

Toronto-Dominion Bank
MMCAP International Inc. SPC
Saba Capital Management
Clear Street Derivatives
Linden Advisors
Blue Owl Capital Holdings
Clear Street
Q Global Advisors
Context Capital Management
Millennium Management
Highland Capital Management Fund Advisors
Susquehanna International
Picton Mahoney Asset Management
Westchester Capital Management
Tenor Capital Management

View all funds holding Phoenix Biotech Acquisition